{
  "DOI": "10.1007/s12687-019-00438-3",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-019-00438-3",
  "alternative-id": [
    "438"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "16 August 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "4 October 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "28 October 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pelletier",
      "given": "S.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Larouche",
      "given": "G.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chiquette",
      "given": "J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "El Haffaf",
      "given": "Z.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Foulkes",
      "given": "W. D.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hamet",
      "given": "P.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Simard",
      "given": "J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3207-8211",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Dorval",
      "given": "M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        10,
        28
      ]
    ],
    "date-time": "2019-10-28T21:08:16Z",
    "timestamp": 1572296896000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        10,
        27
      ]
    ],
    "date-time": "2020-10-27T00:44:23Z",
    "timestamp": 1603759463000
  },
  "funder": [
    {
      "DOI": "10.13039/100016328",
      "doi-asserted-by": "crossref",
      "name": "Quebec Breast Cancer Foundation"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2022,
        11,
        30
      ]
    ],
    "date-time": "2022-11-30T15:54:46Z",
    "timestamp": 1669823686856
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2019,
        10,
        28
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            10,
            28
          ]
        ],
        "date-time": "2019-10-28T00:00:00Z",
        "timestamp": 1572220800000
      }
    },
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            10,
            28
          ]
        ],
        "date-time": "2019-10-28T00:00:00Z",
        "timestamp": 1572220800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-019-00438-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s12687-019-00438-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-019-00438-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "205-213",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        10,
        28
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        10,
        28
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1200/JCO.2003.03.189",
      "author": "American Society of Clinical Oncology",
      "doi-asserted-by": "crossref",
      "first-page": "2397",
      "issue": "12",
      "journal-title": "J Clin Oncol",
      "key": "438_CR1",
      "unstructured": "American Society of Clinical Oncology (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21(12):2397–2406",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1111/jhq.12009",
      "author": "BL Anderson",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "issue": "4",
      "journal-title": "J Healthc Qual",
      "key": "438_CR2",
      "unstructured": "Anderson BL, Pearlman M, Griffin J, Schulkin J (2013) Conflicting and changing breast cancer screening recommendations: survey study of a national sample of ob-gyns after the release of the 2009 USPSTF guidelines. J Healthc Qual 35(4):25–35",
      "volume": "35",
      "year": "2013"
    },
    {
      "DOI": "10.1111/j.1369-7625.2008.00494.x",
      "author": "AD Bakos",
      "doi-asserted-by": "crossref",
      "first-page": "220",
      "issue": "3",
      "journal-title": "Health Expect",
      "key": "438_CR3",
      "unstructured": "Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH (2008) BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Health Expect 11(3):220–231",
      "volume": "11",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10897-007-9090-7",
      "author": "JL Berliner",
      "doi-asserted-by": "crossref",
      "first-page": "241",
      "issue": "3",
      "journal-title": "J Genet Couns",
      "key": "438_CR4",
      "unstructured": "Berliner JL, Fay AM (2007) Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 16(3):241–260",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1001/jama.1997.03540360065034",
      "author": "W Burke",
      "doi-asserted-by": "crossref",
      "first-page": "997",
      "issue": "12",
      "journal-title": "JAMA",
      "key": "438_CR5",
      "unstructured": "Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277(12):997–1003",
      "volume": "277",
      "year": "1997"
    },
    {
      "key": "438_CR6",
      "unstructured": "CHU de Québec (2013). Consulter en génétique: Cancer du sein ou de l’ovaire"
    },
    {
      "DOI": "10.1016/j.pec.2003.11.002",
      "author": "E Claes",
      "doi-asserted-by": "crossref",
      "first-page": "265",
      "issue": "2",
      "journal-title": "Patient Educ Couns",
      "key": "438_CR7",
      "unstructured": "Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E (2004) Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 55(2):265–274",
      "volume": "55",
      "year": "2004"
    },
    {
      "DOI": "10.3200/BMED.31.3.93-106",
      "author": "E Claes",
      "doi-asserted-by": "crossref",
      "first-page": "93",
      "issue": "3",
      "journal-title": "Behav Med",
      "key": "438_CR8",
      "unstructured": "Claes E, Evers-Kiebooms G, Decruyenaere M, Denayer L, Boogaerts A, Philippe K, Legius E (2005) Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer. Behav Med 31(3):93–105",
      "volume": "31",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.breast.2014.06.014",
      "author": "IM Collins",
      "doi-asserted-by": "crossref",
      "first-page": "644",
      "issue": "5",
      "journal-title": "Breast",
      "key": "438_CR9",
      "unstructured": "Collins IM, Steel E, Mann GB, Emery JD, Bickerstaffe A, Trainer A, Butow P, Pirotta M, Antoniou AC, Cuzick J, Hopper J, Phillips KA, Keogh LA (2014) Assessing and managing breast cancer risk: clinicians’ current practice and future needs. Breast 23(5):644–650",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2007.11.0262",
      "author": "SJ Dawson",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "issue": "2",
      "journal-title": "J Clin Oncol",
      "key": "438_CR10",
      "unstructured": "Dawson SJ, Price MA, Jenkins MA, McKinley JM, Butow PN, McLachlan SA, Lindeman GJ, Weideman P, Friedlander ML, Hopper JL, Phillips KA (2008) Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. J Clin Oncol 26(2):225–232",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10549-009-0611-y",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "409",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "438_CR11",
      "unstructured": "Domchek SM, Gaudet MM, Stopfer JE, Fleischaut MH, Powers J, Kauff N, Offit K, Nathanson KL, Robson M (2010) Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Res Treat 119(2):409–414",
      "volume": "119",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ejhg.2010.227",
      "author": "M Dorval",
      "doi-asserted-by": "crossref",
      "first-page": "494",
      "issue": "5",
      "journal-title": "Eur J Hum Genet",
      "key": "438_CR12",
      "unstructured": "Dorval M, Nogues C, Berthet P, Chiquette J, Gauthier-Villars M, Lasset C et al (2011) Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec. Eur J Hum Genet 19(5):494–499",
      "volume": "19",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10897-012-9569-8",
      "author": "C Duprez",
      "doi-asserted-by": "crossref",
      "first-page": "469",
      "issue": "4",
      "journal-title": "J Genet Couns",
      "key": "438_CR13",
      "unstructured": "Duprez C, Christophe V, Milhabet I, Krzeminski A, Adenis C, Berthet P, Peyrat JP, Vennin P (2013) Comparison of the screening practices of unaffected noncarriers under 40 and between 40 and 49 in BRCA1/2 families. J Genet Couns 22(4):469–481",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-13-0316-T",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "2269",
      "issue": "12",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "438_CR14",
      "unstructured": "Evans DG, Ingham SL, Buchan I, Woodward ER, Byers H, Howell A et al (2013) Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 22(12):2269–2276",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1038/sj.bjc.6603610",
      "author": "C Foster",
      "doi-asserted-by": "crossref",
      "first-page": "718",
      "issue": "5",
      "journal-title": "Br J Cancer",
      "key": "438_CR15",
      "unstructured": "Foster C, Watson M, Eeles R, Eccles D, Ashley S, Davidson R, Mackay J, Morrison PJ, Hopwood P, Evans DG, Psychosocial Study Collaborators (2007) Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Br J Cancer 96(5):718–724",
      "volume": "96",
      "year": "2007"
    },
    {
      "DOI": "10.3747/co.23.2961",
      "author": "J Gagnon",
      "doi-asserted-by": "crossref",
      "first-page": "e615",
      "issue": "6",
      "journal-title": "Curr Oncol",
      "key": "438_CR16",
      "unstructured": "Gagnon J, Levesque E (2016) Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol 23(6):e615–e625",
      "volume": "23",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2018.44",
      "author": "F Girardi",
      "doi-asserted-by": "crossref",
      "first-page": "1575",
      "issue": "12",
      "journal-title": "Genet Med",
      "key": "438_CR17",
      "unstructured": "Girardi F, Barnes DR, Barrowdale D, Frost D, Brady AF, Miller C, Henderson A, Donaldson A, Murray A, Brewer C, Pottinger C, Evans DG, Eccles D, EMBRACE, Lalloo F, Gregory H, Cook J, Eason J, Adlard J, Barwell J, Ong KR, Walker L, Izatt L, Side LE, Kennedy MJ, Tischkowitz M, Rogers MT, Porteous ME, Morrison PJ, Eeles R, Davidson R, Snape K, Easton DF, Antoniou AC (2018) Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study. Genet Med 20(12):1575–1582",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.3747/co.24.3759",
      "author": "S Guedaoura",
      "doi-asserted-by": "crossref",
      "first-page": "352",
      "issue": "6",
      "journal-title": "Curr Oncol",
      "key": "438_CR18",
      "unstructured": "Guedaoura S, Pelletier S, Foulkes WD, Hamet P, Simard J, Wong N et al (2017) No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families. Curr Oncol 24(6):352–359",
      "volume": "24",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s11606-016-3973-y",
      "author": "JS Haas",
      "doi-asserted-by": "crossref",
      "first-page": "449",
      "issue": "4",
      "journal-title": "J Gen Intern Med",
      "key": "438_CR19",
      "unstructured": "Haas JS, Barlow WE, Schapira MM, MacLean CD, Klabunde CN, Sprague BL, Beaber EF, Chen JS, Bitton A, Onega T, Harris K, Tosteson ANA, PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortium (2017) Primary care providers’ beliefs and recommendations and use of screening mammography by their patients. J Gen Intern Med 32(4):449–457",
      "volume": "32",
      "year": "2017"
    },
    {
      "author": "J Haggerty",
      "first-page": "1658",
      "journal-title": "Can Fam Physician",
      "key": "438_CR20",
      "unstructured": "Haggerty J, Tudiver F, Brown JB, Herbert C, Ciampi A, Guibert R (2005) Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests. Can Fam Physician 51:1658–1659",
      "volume": "51",
      "year": "2005"
    },
    {
      "DOI": "10.1097/MLR.0b013e318202858e",
      "author": "PK Han",
      "doi-asserted-by": "crossref",
      "first-page": "139",
      "issue": "2",
      "journal-title": "Med Care",
      "key": "438_CR21",
      "unstructured": "Han PK, Klabunde CN, Breen N, Yuan G, Grauman A, Davis WW, Taplin SH (2011) Multiple clinical practice guidelines for breast and cervical cancer screening: perceptions of US primary care physicians. Med Care 49(2):139–148",
      "volume": "49",
      "year": "2011"
    },
    {
      "DOI": "10.1159/000362358",
      "author": "J Jbilou",
      "doi-asserted-by": "crossref",
      "first-page": "190",
      "issue": "4",
      "journal-title": "Public Health Genomics",
      "key": "438_CR22",
      "unstructured": "Jbilou J, Halilem N, Blouin-Bougie J, Amara N, Landry R, Simard J (2014) Medical genetic counseling for breast cancer in primary care: a synthesis of major determinants of physicians’ practices in primary care settings. Public Health Genomics 17(4):190–208",
      "volume": "17",
      "year": "2014"
    },
    {
      "DOI": "10.1186/1471-2407-12-254",
      "author": "LF Jensen",
      "doi-asserted-by": "crossref",
      "first-page": "254",
      "journal-title": "BMC Cancer",
      "key": "438_CR23",
      "unstructured": "Jensen LF, Mukai TO, Andersen B, Vedsted P (2012) The association between general practitioners’ attitudes towards breast cancer screening and women’s screening participation. BMC Cancer 12:254",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ejhg.2010.241",
      "author": "C Julian-Reynier",
      "doi-asserted-by": "crossref",
      "first-page": "500",
      "issue": "5",
      "journal-title": "Eur J Hum Genet",
      "key": "438_CR24",
      "unstructured": "Julian-Reynier C, Mancini J, Mouret-Fourme E, Gauthier-Villars M, Bonadona V, Berthet P, Fricker JP, Caron O, Luporsi E, Noguès C (2011) Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. Eur J Hum Genet 19(5):500–506",
      "volume": "19",
      "year": "2011"
    },
    {
      "author": "N Kadaoui",
      "first-page": "e47",
      "issue": "1",
      "journal-title": "Can Fam Physician",
      "key": "438_CR25",
      "unstructured": "Kadaoui N, Guay M, Baron G, St-Cerny J, Lemaire J (2012) Breast cancer screening practices for women aged 35 to 49 and 70 and older. Can Fam Physician 58(1):e47–e53",
      "volume": "58",
      "year": "2012"
    },
    {
      "DOI": "10.1038/s41436-018-0406-9",
      "author": "A Lee",
      "doi-asserted-by": "crossref",
      "first-page": "1708",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "438_CR26",
      "unstructured": "Lee A, Mavaddat N, Cunningham AP, Carver T, Hartley S, Babb de Villiers C et al (2019) BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med 21(8):1708–1718",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1038/sj.bjc.6604830",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "421",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "438_CR27",
      "unstructured": "Metcalfe KA, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, Royer R, Sun P, Narod SA (2009) Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. Br J Cancer 100(2):421–425",
      "volume": "100",
      "year": "2009"
    },
    {
      "DOI": "10.7785/tcrt.2012.500342",
      "author": "P Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "429",
      "issue": "5",
      "journal-title": "Technol Cancer Res Treat",
      "key": "438_CR28",
      "unstructured": "Metcalfe P, Liney GP, Holloway L, Walker A, Barton M, Delaney GP, Vinod S, Tome W (2013) The potential for an enhanced role for MRI in radiation-therapy treatment planning. Technol Cancer Res Treat 12(5):429–446",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1111/cge.12233",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "issue": "1",
      "journal-title": "Clin Genet",
      "key": "438_CR29",
      "unstructured": "Metcalfe KA, Kim-Sing C, Ghadirian P, Sun P, Narod SA (2014) Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation. Clin Genet 85(1):21–30",
      "volume": "85",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature24284",
      "author": "K Michailidou",
      "doi-asserted-by": "crossref",
      "first-page": "92",
      "issue": "7678",
      "journal-title": "Nature",
      "key": "438_CR30",
      "unstructured": "Michailidou K, Lindstrom S, Dennis J, Beesley J, Hui S, Kar S et al (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551(7678):92–94",
      "volume": "551",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10549-016-4038-y",
      "author": "O Moran",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "438_CR31",
      "unstructured": "Moran O, Nikitina D, Royer R, Poll A, Metcalfe K, Narod SA, Akbari MR, Kotsopoulos J (2017) Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel. Breast Cancer Res Treat 161(1):135–142",
      "volume": "161",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cncr.28771",
      "author": "T Onega",
      "doi-asserted-by": "crossref",
      "first-page": "2955",
      "issue": "19",
      "journal-title": "Cancer",
      "key": "438_CR32",
      "unstructured": "Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, D Schnall M, Armstrong K, Schapira MM, Geller B, Weaver DL, Conant EF (2014) Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer 120(19):2955–2964",
      "volume": "120",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2015.135",
      "author": "S Pelletier",
      "doi-asserted-by": "crossref",
      "first-page": "627",
      "issue": "6",
      "journal-title": "Genet Med",
      "key": "438_CR33",
      "unstructured": "Pelletier S, Wong N, El Haffaf Z, Foulkes WD, Chiquette J, Hamet P et al (2016) Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation. Genet Med 18(6):627–634",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.2003.02.107",
      "author": "BN Peshkin",
      "doi-asserted-by": "crossref",
      "first-page": "4322",
      "issue": "23",
      "journal-title": "J Clin Oncol",
      "key": "438_CR34",
      "unstructured": "Peshkin BN, Isaacs C, Finch C, Kent S, Schwartz MD (2003) Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians. J Clin Oncol 21(23):4322–4328",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2011.37.6483",
      "author": "M Robson",
      "doi-asserted-by": "crossref",
      "first-page": "4477",
      "issue": "34",
      "journal-title": "J Clin Oncol",
      "key": "438_CR35",
      "unstructured": "Robson M (2011) Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation? J Clin Oncol 29(34):4477–4478",
      "volume": "29",
      "year": "2011"
    },
    {
      "key": "438_CR36",
      "unstructured": "SAS Institute Inc (2012). Statistical Analytic System (SAS) v. 9.3, SAS Institute Inc., Cary, NC, "
    },
    {
      "DOI": "10.1089/jwh.2007.0603",
      "author": "KM Schueler",
      "doi-asserted-by": "crossref",
      "first-page": "1477",
      "issue": "9",
      "journal-title": "J Womens Health (Larchmt)",
      "key": "438_CR37",
      "unstructured": "Schueler KM, Chu PW, Smith-Bindman R (2008) Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt) 17(9):1477–1498",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.carj.2016.08.004",
      "author": "JM Seely",
      "doi-asserted-by": "crossref",
      "first-page": "257",
      "issue": "3",
      "journal-title": "Can Assoc Radiol J",
      "key": "438_CR38",
      "unstructured": "Seely JM, Lee J, Whitman GJ, Gordon PB (2017) Canadian radiologists do not support screening mammography guidelines of the Canadian Task Force on Preventive Health Care. Can Assoc Radiol J 68(3):257–266",
      "volume": "68",
      "year": "2017"
    },
    {
      "DOI": "10.1093/jnci/djw290",
      "author": "Yiwey Shieh",
      "doi-asserted-by": "crossref",
      "first-page": "djw290",
      "issue": "5",
      "journal-title": "Journal of the National Cancer Institute",
      "key": "438_CR39",
      "unstructured": "Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A et al (2017) Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J Natl Cancer Inst 109(5)",
      "volume": "109",
      "year": "2017"
    },
    {
      "DOI": "10.1002/ajmg.a.20431",
      "author": "ST Tinley",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "issue": "1",
      "journal-title": "Am J Med Genet A",
      "key": "438_CR40",
      "unstructured": "Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S et al (2004) Screening adherence in BRCA1/2 families is associated with primary physicians’ behavior. Am J Med Genet A 125A(1):5–11",
      "volume": "125A",
      "year": "2004"
    },
    {
      "DOI": "10.1503/cmaj.110334",
      "author": "M Tonelli",
      "doi-asserted-by": "crossref",
      "first-page": "1991",
      "issue": "17",
      "journal-title": "CMAJ",
      "key": "438_CR41",
      "unstructured": "Tonelli M, Gorber SC, Joffres M, Dickinson J, Singh H, Birtwhistle R et al (2011) Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 183(17):1991–2001",
      "volume": "183",
      "year": "2011"
    },
    {
      "author": "F Tudiver",
      "first-page": "682",
      "issue": "8",
      "journal-title": "J Fam Pract",
      "key": "438_CR42",
      "unstructured": "Tudiver F, Brown JB, Medved W, Herbert C, Ritvo P, Guibert R et al (2001) Making decisions about cancer screening when the guidelines are unclear or conflicting. J Fam Pract 50(8):682–687",
      "volume": "50",
      "year": "2001"
    },
    {
      "DOI": "10.1503/cmaj.120392",
      "author": "E Warner",
      "doi-asserted-by": "crossref",
      "first-page": "1803",
      "issue": "16",
      "journal-title": "CMAJ",
      "key": "438_CR43",
      "unstructured": "Warner E, Heisey R, Carroll JC (2012) Applying the 2011 Canadian guidelines for breast cancer screening in practice. CMAJ 184(16):1803–1807",
      "volume": "184",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.bjc.6602207",
      "author": "M Watson",
      "doi-asserted-by": "crossref",
      "first-page": "1787",
      "issue": "10",
      "journal-title": "Br J Cancer",
      "key": "438_CR44",
      "unstructured": "Watson M, Foster C, Eeles R, Eccles D, Ashley S, Davidson R et al (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 91(10):1787–1794",
      "volume": "91",
      "year": "2004"
    }
  ],
  "reference-count": 44,
  "references-count": 44,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s12687-019-00438-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Survey of primary care physicians’ views about breast and ovarian cancer screening for true BRCA1/2 non-carriers"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "11"
}